Showing results (21-30 of 499) with videos related to
Sort By:
Pageof 50
European Journal of Endocrinology|October 3, 2001
Successful treatment of resistant acromegaly with a growth hormone receptor antagonistW M Drake, C Parkinson, S A Akker, et al.European Journal of Endocrinology|March 15, 2005
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomantW M Drake, R A Loureiro, C Parkinson, et al.European Urology|January 1, 1993
Effect of irradiation treatment on gonadal function in men treated for germ cell cancerS M ShaletEuropean Journal of Endocrinology|August 2, 2013
Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologistS M ShaletEuropean Journal of Endocrinology|December 16, 1998
Dose-related effects of growth hormone on IGF-I and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemiaW M Drake, F Miraki, A Siddiqi, et al.Hormone Research|October 10, 2002
Influence of growth hormone on accretion of bone massJ P Monson, W M Drake, P V Carroll, et al.The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegalyP J Trainer, W M Drake, L A Perry, et al.Child'S Brain|January 1, 1982
Growth and hormonal status of children treated for brain tumoursS M ShaletInternational Journal of Clinical Practice|June 13, 1998
Growth hormone therapy for adult growth hormone deficiencyS M ShaletPageof 50